Proteomics: 4.8m people could pay for this biotechnology – and that’s just in the UK! 

Listen to ASX-listed Proteomics MD Dr Richard Lipscombe talk to Matt Birney on the Bulls N’ Bears Report about Proteomics new UK distributor of its remarkable blood test that can predict the onset a particular disease in diabetics before symptoms even appear.

Proteomics: 4.8m people could pay for this biotechnology &ndash; and that&rsquo;s just in the UK! 
Listen to ASX-listed Proteomics MD Dr Richard Lipscombe talk to Matt Birney on the Bulls N&rsquo; Bears Report about Proteomics new UK distributor of its remarkable blood test that can predict the onset a particular disease in diabetics before symptoms even appear.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Advertisement